ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Novo Nordisk A/S B Shares ADRhedged
23.23
-0.5284
-2.22%
盤後：
23.38
0.1473
+0.63%
16:15 EDT
成交量：
453
成交額：
1.06萬
市值：
418.19萬
市盈率：
- -
高：
23.38
開：
23.38
低：
23.23
收：
23.76
52周最高：
34.36
52周最低：
19.00
股本：
18.00萬
流通股本：
18.00萬
量比：
0.47
換手率：
0.25%
股息：
1.69
股息率：
7.29%
淨資產收益率：
--
總資產收益率：
--
市淨率：
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
諾和諾德：2026 年第二季度固定匯率下調整後銷售額增長 7%；固定匯率下調整後營業利潤增長 11%。
智通财经
·
08/05
H1與諾和諾德達成合作，規模化推進人工智能驅動的臨床開發。
智通财经
·
08/04
Hims & Hers Health面臨投資者訴訟調查
环球市场播报
·
08/04
肥胖藥市場競爭再升温，諾和諾德憑藉口服Wegovy重返與禮來的競爭賽道
老虎资讯综合
·
08/03
分析-隨着諾和諾德（Novo）奮力重返競爭行列，與禮來（Lilly）的抗肥胖之戰再度白熱化
路透中文
·
08/03
ETF周報 | 2倍做多微軟ETF升逾45%；2倍做多亞馬遜ETF升逾34%；三倍做多富時中國ETF升逾17%
ETF周报
·
08/02
諾和諾德(NVO)股票7月31日盤中下跌8.75%：投資者必看的核心信息
TradingKey中文
·
08/01
諾和諾德跌超10%！創近五個月以來最大單日跌幅，宣佈心臟新藥臨床試驗失敗
TradingKey中文
·
07/31
美股異動 | 心臟病新藥試驗未達到主要終點 諾和諾德(NVO.US)大跌近10%
智通财经
·
07/31
美股開盤 | 三大指數集體上漲，亞馬遜升逾12%，蘋果跌超9%；存儲股板塊普漲，閃迪升逾8%
老虎资讯综合
·
07/31
心臟新藥試驗失敗！諾和諾德(NVO.US)股價盤前閃崩 「減肥藥依賴症」陰雲加劇
智通财经
·
07/31
諾和諾德股價因心臟病藥物試驗失敗暴跌9%
环球市场播报
·
07/31
盤前異動 | 諾和諾德盤前跌超9%，ZILTIVEKIMAB未展現預期優勢
老虎资讯综合
·
07/31
市場消息：諾和諾德的ZILTIVEKIMAB並未顯示出比安慰劑更低的梅毒風險。
智通财经
·
07/31
諾和諾德(NVO.US)在更新ZEUS三期試驗進展後盤前下跌8.3%。
智通财经
·
07/31
諾和諾德盤前跌超10%公司表示抗炎藥物Ziltivekimab在MACE風險降低方面與安慰劑相比未顯示出顯著差異。
智通财经
·
07/31
諾和諾德美股盤前跌超10%
智通财经
·
07/31
市場消息：諾和諾德公司發布ZEUS III期臨床試驗最新進展，該試驗針對患有動脈粥樣硬化性心血管疾病、慢性腎病和炎症的患
智通财经
·
07/31
ETF日報 | 2倍沽空IREN ETF升逾27%；2倍沽空AAOI ETF漲近27%；三倍沽空半導體ETF升逾16%；科技沽空與原油走強
ETF追踪
·
07/30
諾和諾德因新一代減重新藥遭股東起訴始末
环球市场播报
·
07/29
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/NVOH/news?page=7"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"NVOH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOH\",,,,,undefined,":{"symbol":"NVOH","market":"US","secType":"STK","nameCN":"Novo Nordisk A/S B Shares ADRhedged","latestPrice":23.2327,"timestamp":1789502400000,"preClose":23.7611,"halted":0,"volume":453,"hourTrading":{"tag":"盘后","latestPrice":23.38,"preClose":23.2327,"latestTime":"16:15 EDT","volume":8,"amount":185.5962,"timestamp":1789503300268,"change":0.1473,"changeRate":0.00634,"amplitude":0},"delay":0,"changeRate":-0.022238027700737666,"floatShares":180001,"shares":180001,"eps":0,"marketStatus":"未開盤","change":-0.5284,"latestTime":"09-15 16:00:00 EDT","open":23.38,"high":23.38,"low":23.2327,"amount":10593,"amplitude":0.006199,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789545600000},"marketStatusCode":0,"adr":0,"exchange":"ARCA","adjPreClose":23.7611,"nav":23.761042,"aum":4277011.321042,"dividendRate":0.072923,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":23.38,"preClose":23.2327,"latestTime":"16:15 EDT","volume":8,"amount":185.5962,"timestamp":1789503300268,"change":0.1473,"changeRate":0.00634,"amplitude":0},"volumeRatio":0.47109,"impliedVol":0.2429,"impliedVolPercentile":0.5739},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOH\",,,,,undefined,":{"symbol":"NVOH","floatShares":180001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.47109,"shares":180001,"dividePrice":1.6942,"high":23.38,"amplitude":0.006199,"preClose":23.7611,"low":23.2327,"week52Low":19,"pbRate":"--","week52High":34.36,"institutionHeld":0,"latestPrice":23.2327,"eps":0,"divideRate":0.072923,"volume":453,"delay":0,"ttmEps":0,"open":23.38,"prevYearClose":27.4362,"prevWeekClose":23.4261,"prevMonthClose":24.5859,"prevQuarterClose":26.0576,"fiveDayClose":24.5207,"twentyDayClose":24.4193,"sixtyDayClose":23.4494},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVOH\",params:#limit:5,,,undefined,":[{"date":"2026-06-16","symbol":"NVOH","amount":0.76666,"announcedDate":"2026-06-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-16","defaultRemindTime":1781616600000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-23","payableDate":"2026-06-16","currency":"USD","dateTimestamp":1781582400000,"payDate":"2026-06-23"},{"date":"2026-03-16","symbol":"NVOH","amount":0.27495,"announcedDate":"2026-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-16","defaultRemindTime":1773667800000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-03-16","currency":"USD","dateTimestamp":1773633600000,"payDate":"2026-03-23"},{"date":"2025-12-16","symbol":"NVOH","amount":0.48798,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"},{"date":"2025-09-16","symbol":"NVOH","amount":0.16566,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"Novo Nordisk A/S (B Shares) ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-23","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVOH\",market:\"US\",,,undefined,":[{"executeDate":"2025-09-16","recordDate":"2025-09-16","paymentDate":"2025-09-23","value":0.16566,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.48798,"currency":"USD"},{"executeDate":"2026-03-16","recordDate":"2026-03-16","paymentDate":"2026-03-23","value":0.27495,"currency":"USD"},{"executeDate":"2026-06-16","recordDate":"2026-06-16","paymentDate":"2026-06-23","value":0.76666,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVOH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVOH\",pageSize:20,pageCount:7,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657568841","title":"諾和諾德：2026 年第二季度固定匯率下調整後銷售額增長 7%；固定匯率下調整後營業利潤增長 11%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657568841","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657568841?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 00:34","pubTimestamp":1785861263,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4532","BK4588","BK4599","NVOX","IE00BKVL7J92.USD","OZEM","BK4585","PPH","NVOH","BK4007","NVO","LU0154236417.USD","THNR","LU1093756168.USD","LU1093756325.SGD","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656559761","title":"H1與諾和諾德達成合作，規模化推進人工智能驅動的臨床開發。","url":"https://stock-news.laohu8.com/highlight/detail?id=2656559761","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656559761?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 21:12","pubTimestamp":1785849134,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","BK4599","LU1093756325.SGD","LU1093756168.USD","BK4007","NVOH","THNR","NVO","BK4532","NVOX","IE00BKVL7J92.USD","OZEM","LU0154236417.USD","IE00BZ1G4Q59.USD","PPH","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656309306","title":"Hims & Hers Health面臨投資者訴訟調查","url":"https://stock-news.laohu8.com/highlight/detail?id=2656309306","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656309306?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 03:33","pubTimestamp":1785785580,"startTime":"0","endTime":"0","summary":"律师事务所Kessler Topaz Meltzer & Check， LLP宣布对Hims & Hers Health， Inc．发起调查，代表投资者调查该公司是否存在联邦证券法违规行为。当日盘前，制药公司诺和诺德宣布终止与Hims & Hers的合作伙伴关系，理由是该公司涉嫌非法大规模配制药物并进行欺骗性营销，将患者安全置于风险之中。诺和诺德还指出，Hims & Hers未能遵守禁止大规模销售复方药物的法律。受此消息影响，Hims & Hers股价在2025年6月23日盘中暴跌超20%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-08-04/doc-inimascz5644442.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1093756325.SGD","NVOX","IE00BZ1G4Q59.USD","LU1093756168.USD","BGIA","BK4007","OZEM","BK4588","PPH","BK4599","NVO","NVOH","IE00BKVL7J92.USD","BK4532","LU0154236417.USD","BK4585","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132732205","title":"肥胖藥市場競爭再升温，諾和諾德憑藉口服Wegovy重返與禮來的競爭賽道","url":"https://stock-news.laohu8.com/highlight/detail?id=1132732205","media":"老虎资讯综合","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132732205?lang=zh_tw&edition=fundamental","pubTime":"2026-08-03 13:44","pubTimestamp":1785735844,"startTime":"0","endTime":"0","summary":"诺和诺德与礼来在肥胖药市场的竞争正进入关键阶段。过去两年，礼来凭借Zepbound（替尔泊肽）在美国市场快速扩大份额，股价持续上涨；而诺和诺德则因利润预警、管理层调整以及竞争压力加剧，股价大幅回落。不过，随着口服版Wegovy在美国上市后需求超预期，诺和诺德开始逐步反击，并通过法律行动和加大商业化投入寻求恢复市场信心。两家公司将于8月5日公布财报，市场关注重点将转向肥胖药需求持续性、市场份额变化以及未来增长空间。分析人士认为，肥胖药市场规模预计将在未来十年突破千亿美元，但最终胜负将取决于药物疗效、商业化能力以及企业能否维持长期增长。","market":"us","thumbnail":"https://community-static.tradeup.com/news/b325d3752f8fcafc403af6145a5cd0d7","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/b325d3752f8fcafc403af6145a5cd0d7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOX","LLYX","LLII","ELIL","NVOH","LLY","LLYZ","NVO","ELIS"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2656409403","title":"分析-隨着諾和諾德（Novo）奮力重返競爭行列，與禮來（Lilly）的抗肥胖之戰再度白熱化","url":"https://stock-news.laohu8.com/highlight/detail?id=2656409403","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656409403?lang=zh_tw&edition=fundamental","pubTime":"2026-08-03 13:01","pubTimestamp":1785733262,"startTime":"0","endTime":"0","summary":"尽管诺和诺德近年来在GLP-1注射剂领域市场份额有所下滑，但这家丹麦减肥药制造商正从其新推出的Wegovy减肥药中获得提振，该产品在与礼来公司近期推出的Foundayo的竞争中保持着领先地位。诺和诺德力图“大放异彩”诺和诺德与礼来之间的竞争已蔓延至法庭。礼来公司已否认了这些指控。他表示，诺和诺德需要通过在肥胖治疗领域达成合作协议，才能说服市场相信他们能够与礼来公司长期竞争。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL4T4400AY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ81514606.USD","LLY","LU0689472784.USD","LU1868837300.USD","JDOC","LU2471134879.HKD","SG9999001176.SGD","CANC","LU0471298777.SGD","LU0109391861.USD","IYH","LU0882574139.USD","LU1720051108.HKD","ELIL","IE00BKDWB100.SGD","LU0256863902.USD","LU0456855351.SGD","LU2471134523.USD","BK4599","LU1035775433.USD","LU2746668461.USD","LU1983299246.USD","LU2552382132.HKD","LU0210536198.USD","LU2491049909.HKD","LU2168564149.EUR","LU0266013472.USD","LU1974910355.USD","LU0432979614.USD","LU2023251221.USD","LU1814569148.SGD","LU1127390331.HKD","LU0158827948.USD","LU2063271972.USD","IE00B1XK9C88.USD","LU1551013425.SGD","LU2265009873.SGD","LU2746668974.SGD","SG9999018865.SGD","LU1868836914.USD","LU0417517546.SGD","LU0198837287.USD","LU2264538146.SGD","LU1720051017.SGD","LU2023250504.SGD","LU2111349929.HKD","IE0004445239.USD","SG9999013999.USD","LU2089284900.SGD","LU2756315664.SGD","LU1989771016.USD","SGXZ31699556.SGD","LU0823434740.USD","IE00BJLML261.HKD","LU0820561909.HKD","LU2552382215.SGD","LU1548497426.USD","IE0004445015.USD","FHLC","LU2211815571.USD","LU2750360997.AUD","SG9999015978.USD","LU0154236417.USD","LU2168564222.USD","LU1917777945.USD","LU2324357040.USD","LU2750360641.GBP","LU0203201768.USD","LU2089283258.USD","LU2361044949.HKD","LU0323591593.USD","LU1280957306.USD","LU2028103732.USD","SG9999015952.SGD","IE00BK4W5L77.USD","LU2237443978.SGD","BK4532","LU0238689110.USD","LU2213496289.HKD","LU0234572021.USD","FTXH","LU0353189680.USD","LU1232071149.USD","LU1712237335.SGD","IHE","LU0786609619.USD","LU1323610961.USD","LU2168563687.JPY","LU2756315318.SGD","LU2360106947.USD","IE00BFSS7M15.SGD","IE00BN29S564.USD","LU0106261372.USD","IE00BJJMRX11.SGD","LU0823416689.USD","LU1868836757.USD","LU0640476718.USD","LU1057294990.SGD","LU1093756168.USD","LU2462591350.SGD","LU0316494557.USD","LU2491050154.USD","LU1145028129.USD","IE00BK4W5M84.HKD","BK4585","LU2357305700.SGD","SG9999014906.USD","NVO","IE0009355771.USD","LU0353189763.USD","LU2491050071.SGD","SGXZ51526630.SGD","LU0787776722.HKD","LU2417539215.USD","IE00BKVL7J92.USD","SG9999015986.USD","SGXZ99366536.SGD","LU2237443895.HKD","LU0122379950.USD","LU0466842654.USD","LU0203202063.USD","LU0820561818.USD","LU1623119135.USD","LU2023250330.USD","LU1291159041.SGD","LLYX","LU1804176565.USD","SG9999014898.SGD","LU0097036916.USD","IE0002141913.USD","LU0354030511.USD","LU2237443382.USD","LU2089984988.USD","LU2168564495.EUR","SG9999017495.SGD","LU0820562030.AUD","LU2462157665.USD","LU2896262040.SGD","LU0964807845.USD","LU2471134796.USD","LU0471298694.HKD","LU2112291526.USD","LU0354030438.USD","LU2602419157.SGD","LU1267930730.SGD","IE00B775H168.HKD","IE00BWXC8680.SGD","LU1023059063.AUD","LU0320765992.SGD","LU1093756325.SGD","LU1629891620.HKD","SG9999014914.USD","VHT","NVOX","LU0158827781.USD","ELIS","GB00BDT5M118.USD","LU0385154629.USD","IE00BJJMRY28.SGD","IE00B1BXHZ80.USD","LU0114720955.EUR","LU1061106388.HKD","LU1069344957.HKD","LU2087625088.SGD","LU1064131342.USD","BK4534","LU2271345857.HKD","IE00BFTCPJ56.SGD","THNR","LU0079474960.USD","LU2106854487.HKD","MHIP","LU0006306889.USD","BK4588","LU0345770993.USD","LU0882574055.USD","MEDI","IE0001KFT4U8.USD","IE00BFSS8Q28.SGD","LU0943347566.SGD","TRUH","LU2552382058.USD","RXL","LU0094547139.USD","HRTS","OZEM","LU2361045086.USD","SGXZ57979304.SGD","LU1868837136.USD","IXJ","LU0683600562.USD","SG9999014880.SGD","LU0109394709.USD","LLII","LU0058720904.USD","LU2237443622.USD","LU0823434583.USD","PJP","PPH","LU0061475181.USD","CURE","LU2456880835.USD","SG9999001176.USD","TMED","GDOC","LU0345770308.USD","BK4533","LU1551013342.USD","LU0225283273.USD","LU1988902786.USD","LU0133085943.USD","LU2237443549.SGD","LU0889565916.HKD","IE00B7KXQ091.USD","LU2236285917.USD","LLYZ","LU2168564065.EUR","SG9999015945.SGD","LU2461242641.AUD","ILDR","LU0708995401.HKD","LU1979441026.SGD","LU2108987350.USD","AGNG","BK4516","LU0256863811.USD","LU2237438978.USD","LU0289739699.SGD","LU2237443465.HKD","LU2361044865.SGD","IE00BZ1G4Q59.USD","IE00B4R5TH58.HKD","LU0096364046.USD","LU2468319806.SGD","LU1366192091.USD","NVOH","IE00B4JS1V06.HKD","LU0320765059.SGD","XLV","IE00BJT1NW94.SGD","MEDX","LU2471134952.CNY","SG9999018857.SGD","WDNA","LU1868836591.USD","BK4581","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","BK4007","IE00BKPKM429.USD","LU0174119429.USD","IE0005OL40V9.USD","LU0672654240.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193230055","title":"ETF周報 | 2倍做多微軟ETF升逾45%；2倍做多亞馬遜ETF升逾34%；三倍做多富時中國ETF升逾17%","url":"https://stock-news.laohu8.com/highlight/detail?id=1193230055","media":"ETF周报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193230055?lang=zh_tw&edition=fundamental","pubTime":"2026-08-02 06:30","pubTimestamp":1785623400,"startTime":"0","endTime":"0","summary":"本周ETF层面，科技龙头相关杠杆产品领涨，做空贵金属与原油的产品亦录得涨幅。美股ETF本周涨幅Top52倍做多MSFT ETF-Direxion上涨45.11%。该产品两倍做多比特币矿企Riot Platforms，底层公司股价走弱，杠杆机制放大本周跌幅。2倍做多QCOM ETF-GraniteShares下跌22.65%。大盘指数ETF涨幅Top 5三倍做多富时中国ETF-Direxion上涨17.22%。二倍做多富时中国50ETF上涨10.49%。大宗商品ETF涨幅Top 5做空黄金ETN(德银)上涨8.45%。三倍做空半导体ETF-Direxion Daily上涨5.28%。两倍做空房地产ETF-ProShares上涨3.97%。债券ETF涨幅Top 5First Trust Emerging Markets Local Currency Bond ETF上涨1.21%。","market":"us","thumbnail":"https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1868837300.USD","ASHR","LU0320765059.SGD","CGGO","MIDU","LU1914381329.SGD","LU0070302665.USD","LU0949170426.SGD","TRFK","LU0823421416.USD","LU1564329628.SGD","IE00BBT3K403.USD","LU1084165304.USD","LU0444973449.USD","CLIX","LU1815336760.USD","SG9999018865.SGD","LU2125154778.USD","FDTX","LU2065171311.SGD","LU2054465674.USD","LU0211331839.USD","LU0072462426.USD","SG9999000418.SGD","LU0894486033.HKD","SGOL","FTXO","BTGD","LU2237443622.USD","BK4575","LU1551013342.USD","LU1989772840.SGD","USXF","YGLD","IE00B4JS1V06.HKD","LU0557290698.USD","LU0203201768.USD","LU0157215616.USD","LU2505996509.AUD","BK4604","LU2087621335.USD","TTXU","LU2148611432.USD","LU0345768740.USD","TYLG","GDXD","LU1674673691.USD","LU1861559042.SGD","LU0289739343.SGD","LU1244550494.USD","IE0004086264.USD","LU1069344957.HKD","LU2860962120.EUR","LU1868836757.USD","EFIV","IE00BZ1G4Q59.USD","UYM","LU2458330243.SGD","SGXZ99366536.SGD","LU2347655073.USD","LU2083900584.USD","IGLD","LU2092627202.USD","LU1629891620.HKD","LU1571399168.USD","IE00BN29S564.USD","LU0314104364.USD","LU2210149790.SGD","LU2028103732.USD","LU0545562505.USD","SOXS","XLF","LU1228905037.USD","LU1732799900.SGD","LU1880398471.USD","BK4527","HULL","LU1979441026.SGD","LU2326559502.SGD","LU2357305700.SGD","LU2430703095.HKD","IE00BQXX3D17.EUR","BK4504","LU0426412945.USD","LU2403377893.USD","LU0081259029.USD","BAR","LU1804176565.USD","LU2506951875.HKD","NVOH","LU2756315664.SGD","SPYM","SPYU","LU0690374961.EUR","LU0994945656.USD","LU2102340556.USD","LU1046421795.USD","LU1823568750.SGD","LU2381873111.SGD","JPO","LU1116320737.USD","GLD","FXP","LU2168564065.EUR","SPYQ","LU0203347892.USD","LU0963586101.USD","LU2430703251.USD","BK4548","BOBP","LU2242649171.HKD","LU0265550359.USD","LU0128525929.USD","LU1951198990.SGD","LU0719512351.SGD","LU0069063385.USD","YXI","IE00BLSP4239.USD","BK4567","LU0251132253.USD","LU0689472784.USD","LU0312595415.SGD","BNDW","GLL","SMAX","SG9999015358.SGD","IGV","GOLY","LU1935042488.USD","LU2191332357.HKD","LU1119994496.HKD","LU0302445910.USD","COZX","IE00BKVL7J92.USD","LU1778281490.HKD","LU2361045086.USD","DDM","LU2462591277.SGD","LU2247934214.USD","LU0784383803.USD","LU2360108059.USD","LU0211328371.USD","LU2236285917.USD","LU0980610538.SGD","LU1642822529.SGD","LU1883839398.USD","LU0323240290.USD","LU0106831901.USD","LU0820561818.USD","UDOW","DULL","LU0648000940.SGD","IE00BSNM7G36.USD","LU0106261372.USD","LEMB","LU0203345920.USD","UYG","IE00BDRTCR15.USD","YSPY","LU0267386448.USD","IE000KEQY171.SGD","DMAX","IE00BKDWB100.SGD","NBIC","TFNS","LU1032466523.USD","LU2506952170.USD","MCHI","AGQ","LU0965509283.SGD","WUGI","LU2552382058.USD","LU2023250843.SGD","LU0006306889.USD","BK4566","LU1366192091.USD","LU2463028550.USD","LU0048573561.USD","CQQQ","LU0061474705.USD","LU0342679015.USD","LU1267930813.SGD","SPXL","LU1340139317.AUD","LU1935043536.SGD","BK4598","IE0004445015.USD","SGDM","FXL","IE0001KFT4U8.USD","IE00BJJMRY28.SGD","LU1181866309.USD","LU2125154935.USD","PHYS","SPTE","LU2023250504.SGD","LU1244550577.SGD","LU2286300806.USD","BK4533","LU2360107168.USD","LU2433249047.HKD","LU0395794307.EUR","IE00BK4W5L77.USD","LU2954938101.SGD","LU2471134879.HKD","LU2125909247.SGD","LU1989764664.SGD","LU2746668461.USD","IE00BYQQ9H92.USD","LU0985320562.USD","IE00BGHQDM52.EUR","LU0823411888.USD","WLDR","LU0308772762.SGD","LU1670711040.USD","LU2077746001.SGD","IE0009356076.USD","ASHS","LU2458330169.SGD","LU2097344357.USD","SNPE","BK4550","FDN","LU2125909593.SGD","SG9999014880.SGD","LU0456855351.SGD","LU2237443382.USD","LU1244550221.USD","LU2362541273.HKD","LU0215105999.USD","IE00BVYPNQ40.USD","LU1720051108.HKD","SG9999015952.SGD","BK4600","FAI","LU2505996681.GBP","GDXJ","LU1852331112.SGD","LU0957808578.USD","IE000F7OJYX1.SGD","LU0347712357.USD","LU1267930490.SGD","LU2097829019.USD","LU1435385759.SGD","LU2552382215.SGD","BK4592","CMAG","LU0894485498.HKD","IE00BMPRXQ63.HKD","LU2097344431.USD","LU1201861249.SGD","SGXZ23171101.USD","LU2360106780.USD","LU2896262040.SGD","LU1221951046.USD","LU1861127337.USD","HK0000914660.USD","LU0070217475.USD","LU0211326755.USD","BK4543","LU1145028129.USD","LU1585245621.USD","LU0310800379.SGD","OSSL","IE000ITXATA3.USD","IXG","IE00B5TLWC47.USD","IE00BQXX3C00.GBP","LU0949170772.SGD","LU0323239441.USD","CHPX","DRV","LU2357627491.SGD","RING","BK4605","IE00B19Z8W00.USD","ARTY","LU1228905540.USD","LU0976567544.SGD","LU1582987597.SGD","LU0912757837.SGD","LU1670710661.SGD","BK4207","LU0942090050.USD","LU0353189763.USD","BK4524","TEUP","LU2095319765.USD","LU1668664300.SGD","YANG","LU2065170008.USD","DRAG","LU3102509885.SGD","LU0256863902.USD","LU1670627923.USD","LU2211817866.USD","LU1791710582.SGD","LU2750360641.GBP","IE00B3S45H60.SGD","LU1868836914.USD","LU0158827781.USD","LU1043141396.HKD","LU1951200564.SGD","LU2244417387.USD","WANT","GLDY","SHNY","XX25.UK","LU2041044095.USD","CHAT","LU1267930573.SGD","LU2106854487.HKD","LU1066051225.USD","JNUG","LU1894683348.USD","LU2089284900.SGD","82822","BK4595","GDXY","LU1732800096.USD","LU1127390331.HKD","LU2756315318.SGD","SG9999014567.USD","USG","LU2211815571.USD","SGXZ51526630.SGD","XNTK","LU0494093205.USD","LU0096362180.USD","LU1400636657.SGD","LU1066051498.USD","82843","SGXZ80539844.SGD","LU1691799644.USD","GLDM","LU0170899867.USD","LU0672654240.SGD","LU0757359368.USD","IE000W1ABFV2.USD","LU0792757196.USD","IE00BDCRKT87.USD","CHAU","BK4534","LU2317271919.USD","LU0133085943.USD","LU0757359954.USD","LU0238689110.USD","LU0345770993.USD","LU0210528500.USD","AMZZ","LU2543165471.USD","SG9999014914.USD","UMDD","IE00BFXG1179.USD","FTEC","LU0426417589.USD","LU2487616109.SGD","LU1301847155.USD","LU0353189680.USD","NVTC","LU2133065610.SGD","SG9999004303.SGD","IE000WAW04H5.SGD","LU1316542783.SGD","FGDL","LU1861558580.USD","LU0345769631.USD","SGXZ44715902.SGD","IE00BLSP4452.SGD","SG9999015945.SGD","LU1202635105.USD","LU0354030511.USD","BK4588","PGJ","LU2452424414.USD","LU0130103400.USD","LU0265550946.USD","SMH","TDV","LU2089985449.USD","LU1334329650.SGD","LU2361044865.SGD","CWEB","LU1935043023.USD","IE0002270589.USD","LU0211326839.USD","LU1935042215.USD","BK4528","LU0354030438.USD","IE00BN8TJ469.HKD","LU0316494557.USD","IBLC","LU1429558221.USD","LU2506951958.HKD","BK4516","BK4532","LU0788109477.HKD","LU1564329032.USD","LU2404859741.USD","LU1674673428.USD","LU0210533765.USD","LU1974910355.USD","LU0950375773.USD","LU2168564495.EUR","SG9999018857.SGD","LU1506573853.SGD","SPXU","BK4612","LU0061475181.USD","LU0072461881.USD","LU2048586759.USD","IE00B775SV38.USD","LU2430703178.SGD","LU2462157665.USD","LU0957791311.USD","IE0034235188.USD","LU1236620750.USD","ONTX","IYG","LU0082616367.USD","SG9999014906.USD","IE00BJJMRX11.SGD","IE00BMPRXN33.USD","LU0823417737.USD","LU2592432038.USD","LU2602419157.SGD","LU2279689827.SGD","BK4141","IE00BK4W5M84.HKD","RGTC","LU0708995401.HKD","IE00B1XK9C88.USD","IE00BJTD4V19.USD","SGXZ81514606.USD","NULC","HBMX","LU2417539215.USD","LU0077335932.USD","LU1037948541.HKD","LU2764263039.SGD","LU0823434740.USD","LU1935042991.SGD","LU1989772923.USD","LU0320765489.SGD","LU1035773651.USD","BK4007","SCO","LU2462591350.SGD","IYF","LU0174119429.USD","LU1934455863.HKD","IE00B7KXQ091.USD","DGZ","FTXL","IE00BJTD4N35.SGD","AAAU","BK4525","LU1720051017.SGD","IE00BFSS7M15.SGD","LU1116320901.HKD","LU1633808545.USD","LU1934455194.USD","MMAX","LU1162221912.USD","LU0149725797.USD","SPY","LU0225283273.USD","LU0661504455.SGD","LU1670628061.USD","DBP","NVOX","LU0061474960.USD","LU0861579265.USD","LU0642271901.SGD","BK4535","LU0251142724.SGD","02843","LU0971096721.USD","LU2237443465.HKD","LU0314106906.USD","LU2065169927.USD","LU0784385840.USD","LU0130102774.USD","SH","02823","EBND","LU1069347547.HKD","LU2362540622.SGD","LU2092937221.SGD","IE000SO60NU8.SGD","LU2087625088.SGD","LU0444971666.USD","LU2250418816.HKD","PFXF","LU0640476718.USD","LU1043141123.HKD","BK4097","BK4122","PSI","IETC","IE00BKPKM429.USD","LU0545039389.USD","LU2065171402.SGD","LU0795875169.SGD","SHOC","LU0472753341.HKD","LU2471134796.USD","KBWB","LU0289941410.SGD","LU2237443895.HKD","LU2237443978.SGD","LU2750360997.AUD","IE00BQXX3F31.USD","LU0095938881.EUR","IE0009G5SDU7.USD","LU0198837287.USD","LU2420271590.USD","LU0511384066.AUD","IAUM","IXN","LU2210150020.SGD","AIQ","LEGR","IE00BWXC8680.SGD","IE0005OL40V9.USD","IE00BJLML261.HKD","LU1861220033.SGD","HIBL","BK4503","TDIV","LU2237957902.USD","LU2275660780.HKD","SOXQ","DISK","LU0528227936.USD","LU1003077747.HKD","LU2290526834.HKD","SG9999002232.USD","LITC","LU1582986359.USD","BK4551","LU2100268510.USD","IE00BHPRN162.USD","LU1582986433.USD","LU2491050154.USD","LU2213496289.HKD","LU2047632596.USD","LU0823417653.USD","LU0724617625.USD","LU0251131958.USD","BK4577","LU2237957811.SGD","LU0742534661.SGD","LU1551013425.SGD","SDS","SG9999002224.SGD","VRC","EMSF","LU2471134523.USD","LU0211327993.USD","LU1721428933.USD","LU1074936037.SGD","LU1645745479.HKD","BK4553","LU1988902786.USD","SG9999001424.SGD","LU0964807845.USD","BAI","LU0203202063.USD","LU1196500208.SGD","IE00BVYPNP33.GBP","IE0000B7K699.USD","IE00B19Z3581.USD","PTF","LU1803068623.USD","LU2089283258.USD","IE0004091025.USD","LU2413666699.HKD","LU0266013472.USD","XW","BK4559","LU1868836591.USD","LU0094547139.USD","LU2111349929.HKD","XLY","LU0708994859.HKD","LU1032955483.USD","LU0390134368.USD","FEMB","IE00BYXW3230.USD","GOAU","DGP","JGRO","BK4561","SPYH","FLCH","KGLD","LU0417517546.SGD","LU1400636491.USD","82823","LU1839511570.USD","LU1815333072.USD","CHPS","LU1366333091.USD","BGLD","IE00BFXG0V08.USD","LU2931357623.SGD","LU0210536198.USD","IE000BZT7R73.USD","SG9999014559.SGD","LU0345774391.USD","LU2265009873.SGD","BK7050","ETNG","IE00B7SZLL34.SGD","LU0553294199.USD","LU1496350502.SGD","OUNZ","LU0496365809.HKD","LU1989763005.USD","LU2361044949.HKD","LU2764263203.CNY","IE00B1BXHZ80.USD","IE00B3SWFQ91.USD","LU0965509010.AUD","CEF","LU1923623000.USD","IE0004445239.USD","02822","GDXU","LU1670710588.SGD","IE00B775H168.HKD","LU0320765646.SGD","HK0000819398.USD","LU1236620834.HKD","LU2063271972.USD","SIVR","LU2242650005.HKD","AIFD","LU1670711123.USD","ROM","BK4581","LU0138981039.USD","LU1868837136.USD","LU0689626769.HKD","GB00BDT5M118.USD","HK0000304797.USD","LU2264538146.SGD","LU1894683264.USD","IE00BFSS8Q28.SGD","IVV","LU0057025933.USD","BLOX","LU0289961442.SGD","FXI","SG9999015341.SGD","LU1623119135.USD","BK4512","LU0795875086.SGD","SG9999017495.SGD","LU0143551892.USD","LU1880398554.USD","LU1280957306.USD","DIA","LU2360032135.SGD","IE000M9KFDE8.USD","LU1221951129.SGD","LU1934455277.USD","LU0345768153.USD","UGL","KWEB","BK4587","IE00B19Z9505.USD","LU1188199696.SGD","LU0171293334.USD","LU1548497426.USD","LU0889566641.SGD","LU0127658192.USD","LU1066051811.HKD","SDOW","LU2237443549.SGD","BK4596","LU1670756490.USD","IAUI","FNGZ","LU0348723411.USD","LU0056508442.USD","LU1064131342.USD","SG9999014575.USD","SIMX","LU0080751232.USD","SOXX","DBC","LU0965508806.USD","BK4554","LU0889565833.HKD","LU1232071149.USD","SG9999015986.USD","VFH","LFGY","XPP","SPUU","LU0029864427.USD","LU2491049909.HKD","LU2746668974.SGD","JDST","IE0034235303.USD","LU2999663052.SGD","LU1496350171.SGD","LU0234572021.USD","GAMR","LU0234570918.USD","LU0738911758.USD","ONLN","SLV","LU1803068979.SGD","LU0323591593.USD","LU2404859667.USD","TRUF","HK0000532082.HKD","LU0107464264.USD","XLK","LU0784384876.USD","LU0859254822.USD","LU0868494617.USD","LU0786609619.USD","LU1697837992.HKD","LU1153585028.USD","LU1582987324.SGD","VGT","LU2506952097.USD","LU0345774631.USD","SSO","LU0208291251.USD","LU1861215975.USD","LU2298321311.HKD","LU0871640123.AUD","SGXZ31699556.SGD","IE0003U64NQ7.SGD","LU0690374615.EUR","LU2271345857.HKD","IE000YTNTUN2.SGD","LU1791710400.SGD","DXD","LU1989764748.USD","IE0034235295.USD","LU1235295455.SGD","LU2471134952.CNY","BKCH","LU0158827948.USD","LU2764262908.HKD","DOG","BK4614","LU0965509101.SGD","LU1923622614.USD","BK4538","LU0466842654.USD","LU0079474960.USD","LU1267930730.SGD","LU0048584097.USD","DUST","LU0162691827.USD","SPDN","LU2456880835.USD","AIS","LU0053666078.USD","GBUG","IE00B5949003.HKD","IE00B19Z8X17.USD","OGIG","LU2168564149.EUR","RTH","LU2461242641.AUD","PALL","LU2552382132.HKD","ZSL","RULE","LU1059921491.USD","LU1564329115.USD","LU2720916845.USD","SRS","BK4515","LU0276348264.USD","YINN","GB00B4LPDJ14.GBP","LU0820562030.AUD","LU2168563687.JPY","DZZ","LU0256863811.USD","LU1718418525.SGD","LU1037948897.HKD","LU0683600562.USD","IE000MB6IJN5.SGD","LU2108987350.USD","LU2362541513.USD","LU1363072403.SGD","SG9999014898.SGD","LU0011850046.USD","BK4573","ILDR","LU1323610961.USD","LU2023250330.USD","LU2168564222.USD","LU0823421333.USD","LU0960925559.SGD","VOO","BK4579","LU1201861165.SGD","LU2491050071.SGD","DAPP","LU0274383776.USD","SAA","LU0109391861.USD","LU0154236417.USD","ALA","LU0823434583.USD","LU1035775433.USD","LU0868494708.USD","EBND.AU","MVV","LU1983260115.SGD","IE00B4YYXB79.USD","LU2023251221.USD","LU0124676726.USD","BK4507","LU0175139822.USD","IAU","LU1917777945.USD","LU0345769128.USD","LU1814569148.SGD","LU2237438978.USD","LU0345770308.USD","LU1066053197.SGD","LU1989773731.SGD","LU2413666426.HKD","FNCL","BK4023","HK0000304805.HKD","LU0476273544.USD","GDX","LU2637965513.SGD","LU0787776722.HKD","LU0648001328.SGD","LU0943347566.SGD","UPRO","SG9999001077.SGD","LU1712237335.SGD","LU0187121727.USD","LU0289960550.SGD","LU0310799852.SGD","LU0879622024.SGD","BK4585","LU2347655156.SGD","HK0000914686.HKD","SPXS","MSFU","IE00B19Z3B42.SGD","LU0882574139.USD","LU0096364046.USD","LU1430594728.SGD","SG9999015978.USD","LU0820561909.HKD","LU1121112475.USD","LU0784385170.HKD","GB00B4QBRK32.GBP","EGGY","LU1235294995.USD","EMLC","LU1400636574.HKD","LU2092937148.SGD","LU1261432733.SGD","LU0726765562.USD","BK4220","IE00BMPRXR70.SGD","LU1564329461.SGD","LU0097036916.USD","SG9999014542.SGD","CNEQ","DRMY","LU0109392836.USD","BK4576"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2656398139","title":"諾和諾德(NVO)股票7月31日盤中下跌8.75%：投資者必看的核心信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2656398139","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656398139?lang=zh_tw&edition=fundamental","pubTime":"2026-08-01 00:16","pubTimestamp":1785514597,"startTime":"0","endTime":"0","summary":"• 由于季度指引令人失望且竞争压力加剧，诺和诺德股价下跌。\n• 运营成本上升和供应链受阻正对该公司的利润率产生负面影响。\n• 围绕美国药品定价的立法不确定性加剧了对其未来营收增长的担忧。","market":"fut","thumbnail":"https://resource.tradingkey.com/uploads/20260204/novo-097495ca9dea48fc8abd9bbb031282c3.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260204/novo-097495ca9dea48fc8abd9bbb031282c3.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262067948-market-movers-nvo-20260731","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOH","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4599","LU0154236417.USD","BK4585","PPH","LU1093756325.SGD","OZEM","LU1093756168.USD","THNR","NVOX","NVO","BK4007","BK4532","BK4588"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2656398133","title":"諾和諾德跌超10%！創近五個月以來最大單日跌幅，宣佈心臟新藥臨床試驗失敗","url":"https://stock-news.laohu8.com/highlight/detail?id=2656398133","media":"TradingKey中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656398133?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 23:41","pubTimestamp":1785512495,"startTime":"0","endTime":"0","summary":"美东时间7月31日，诺和诺德（NVO）一度跌超10%，创自2026年2月23日以来最大单日跌幅，截至发稿，仍跌8.84%，报47.05美元。据悉，诺和诺德周五宣布，其备受关注的在研心脏新药ziltivekimab在一项大型后期临床试验中未能达到主要终点。","market":"nz","thumbnail":"https://resource.tradingkey.com/uploads/20260204/novo-097495ca9dea48fc8abd9bbb031282c3.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260204/novo-097495ca9dea48fc8abd9bbb031282c3.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/analysis/stocks/us-stock/262067893-novo-nordisk-nvo-crash-10-percent-ziltivekimab-heart-drug-zeus-trial-fails-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","PPH","NVO","BK4585","IE00BKVL7J92.USD","LU1093756168.USD","LU1093756325.SGD","BK4599","NVOH","BK4588","OZEM","LU0154236417.USD","BK4007","THNR","NVOX","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655362997","title":"美股異動 | 心臟病新藥試驗未達到主要終點 諾和諾德(NVO.US)大跌近10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2655362997","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655362997?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 22:16","pubTimestamp":1785507386,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4007","BK4585","IE00BKVL7J92.USD","LU1093756325.SGD","LU0154236417.USD","IE00BZ1G4Q59.USD","NVOH","BK4588","THNR","BK4599","BK4532","LU1093756168.USD","OZEM","PPH","NVOX","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168627446","title":"美股開盤 | 三大指數集體上漲，亞馬遜升逾12%，蘋果跌超9%；存儲股板塊普漲，閃迪升逾8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168627446","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168627446?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 21:31","pubTimestamp":1785504670,"startTime":"0","endTime":"0","summary":"7月31日，美股三大指数开盘集体上涨，道指涨0.48%，纳指涨0.87%，标普500涨0.5%。存储股板块， 闪迪涨超8%，SK海力士、希捷涨超7%， 美光涨超5%；亚马逊涨超12%，AWS以37%的超预期增速回应AI烧钱质疑，市场无视现金流转负、资本开支上调；苹果跌超9%，上季iPhone收入增22%略超预期，但服务和中国市场业绩逊色，示警供应短缺伤害；诺和诺德跌近8%，公布ZEUS心血管3期试验主要结果，Ziltivekimab在MACE风险降低方面与安慰剂相比未显示出显著差异。","market":"us","thumbnail":"https://static.tigerbbs.com/ff6e3231d788a5a6d28cf7965385cc7f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ff6e3231d788a5a6d28cf7965385cc7f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","AMZU","MUZ","SPYH","SPYU","IVV","UDOW","AAPD","MUYY","SNDU","SPYQ","SNDK","SNDC","SKUU","AMZN",".IXIC","PTF","SH","SKHX","LU2360107168.USD","STX","AAPX","MUU","BK4170","SMAX","AMZY","SPDN","AAPW","SNDG","AAPB","HYNX","UUP","NVOH","AMZZ","AAPU","SPY","SKHY","MMAX","AAPY","DXD","UPRO","SNDQ","SPXS","SPYM","MIC","SKHU",".DJI","SNXX","NVO","NVOX","07709","SPXU","SSO","AAPL","AMZW","UDN","RAM","DRAM","SKDD","MULL","YSPY","SKHZ","LU0963586101.USD","MU","DDM","CNAV","SDS","DOG","VOO","AMZD","APLY","SPXL","SK","DIA","LU2290526834.HKD","LU0054578231.USD","SDOW","LU1861215975.USD",".SPX","AMZP","SPUU","HIBL","MUD","AZYY","LU1861220033.SGD","DMAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655436948","title":"心臟新藥試驗失敗！諾和諾德(NVO.US)股價盤前閃崩 「減肥藥依賴症」陰雲加劇","url":"https://stock-news.laohu8.com/highlight/detail?id=2655436948","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655436948?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 20:54","pubTimestamp":1785502475,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，丹麦制药巨头诺和诺德遭遇重大研发挫折，该公司周五宣布，其备受关注的在研心脏新药ziltivekimab在一项大型后期临床试验中未能达到主要终点，消息导致其股价盘中一度暴跌逾10%。安全性方面，两组总体不良事件发生率相近，但ziltivekimab组的严重感染发生率更高，总体死亡率则无差异。此次主要终点未达成，对这家丹麦制药商而言无疑是又一次打击。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1474849.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK4532","IE00BKVL7J92.USD","NVO","IE00BZ1G4Q59.USD","OZEM","LU0154236417.USD","LU1093756325.SGD","PPH","BK4007","NVOX","BK4585","LU1093756168.USD","BK4599","NVOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655366893","title":"諾和諾德股價因心臟病藥物試驗失敗暴跌9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2655366893","media":"环球市场播报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655366893?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 20:05","pubTimestamp":1785499500,"startTime":"0","endTime":"0","summary":"诺和诺德公司表示，其一项针对心脏病药物的后期临床试验未能比安慰剂更有效地减少重大心血管事件，该公司股价随即一度暴跌10%。诺和诺德在周五的一份声明中称，虽然其实验性药物ziltivekimab确实显示出一些生物学效应，但并未转化为对特定疾病患者在统计学上有意义的MACE降低——MACE定义为心血管死亡、非致命性心脏病发作或非致命性中风。诺和诺德在哥本哈根上市的股票最后报价下跌8.6%，其美国存托凭证在盘前交易中下跌9.8%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-07-31/doc-iniktcvf1201961.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["NVO","NVOX","OZEM","LU1093756168.USD","BK4585","PPH","BK4599","BK4532","BK4007","IE00BZ1G4Q59.USD","LU1093756325.SGD","IE00BKVL7J92.USD","NVOH","BK4588","THNR","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169208669","title":"盤前異動 | 諾和諾德盤前跌超9%，ZILTIVEKIMAB未展現預期優勢","url":"https://stock-news.laohu8.com/highlight/detail?id=1169208669","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169208669?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 19:36","pubTimestamp":1785497783,"startTime":"0","endTime":"0","summary":"7月31日，诺和诺德盘前跌超9%，报46.92美元。消息面上，诺和诺德更新试验进展，ZILTIVEKIMAB并未显示出比安慰剂更低的梅毒风险。","market":"us","thumbnail":"https://community-static.tradeup.com/news/4329774b45b3f3cd5c378e0673a03a23","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/4329774b45b3f3cd5c378e0673a03a23"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"盘前异动 | 诺和诺德盘前跌超9%，ZILTIVEKIMAB未展现预期优势","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOX","NVO","NVOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655676363","title":"市場消息：諾和諾德的ZILTIVEKIMAB並未顯示出比安慰劑更低的梅毒風險。","url":"https://stock-news.laohu8.com/highlight/detail?id=2655676363","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655676363?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 19:27","pubTimestamp":1785497220,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BZ1G4Q59.USD","LU1093756168.USD","BK4599","BK4007","LU0154236417.USD","THNR","IE00BKVL7J92.USD","OZEM","NVOX","BK4585","PPH","LU1093756325.SGD","NVO","NVOH","BK4532","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655636723","title":"諾和諾德(NVO.US)在更新ZEUS三期試驗進展後盤前下跌8.3%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2655636723","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655636723?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 19:26","pubTimestamp":1785497174,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1093756168.USD","BK4585","PPH","BK4588","IE00BKVL7J92.USD","THNR","IE00BZ1G4Q59.USD","NVOX","BK4007","NVOH","NVO","OZEM","LU1093756325.SGD","LU0154236417.USD","BK4532","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655363429","title":"諾和諾德盤前跌超10%公司表示抗炎藥物Ziltivekimab在MACE風險降低方面與安慰劑相比未顯示出顯著差異。","url":"https://stock-news.laohu8.com/highlight/detail?id=2655363429","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655363429?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 19:26","pubTimestamp":1785497160,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NVOH","THNR","BK4588","BK4007","IE00BKVL7J92.USD","OZEM","LU0154236417.USD","NVOX","PPH","BK4599","BK4532","LU1093756168.USD","BK4585","IE00BZ1G4Q59.USD","LU1093756325.SGD","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655500363","title":"諾和諾德美股盤前跌超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2655500363","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655500363?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 19:22","pubTimestamp":1785496944,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","NVOX","LU1093756325.SGD","BK4588","BK4532","LU1093756168.USD","PPH","NVOH","THNR","NVO","OZEM","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4007","LU0154236417.USD","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655597363","title":"市場消息：諾和諾德公司發布ZEUS III期臨床試驗最新進展，該試驗針對患有動脈粥樣硬化性心血管疾病、慢性腎病和炎症的患","url":"https://stock-news.laohu8.com/highlight/detail?id=2655597363","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655597363?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 19:20","pubTimestamp":1785496856,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4007","BK4585","IE00BKVL7J92.USD","LU1093756325.SGD","LU0154236417.USD","IE00BZ1G4Q59.USD","NVOH","BK4588","THNR","BK4599","BK4532","LU1093756168.USD","OZEM","PPH","NVOX","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153012517","title":"ETF日報 | 2倍沽空IREN ETF升逾27%；2倍沽空AAOI ETF漲近27%；三倍沽空半導體ETF升逾16%；科技沽空與原油走強","url":"https://stock-news.laohu8.com/highlight/detail?id=1153012517","media":"ETF追踪","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153012517?lang=zh_tw&edition=fundamental","pubTime":"2026-07-30 08:20","pubTimestamp":1785370800,"startTime":"0","endTime":"0","summary":"美股ETF涨幅Top5Tradr 2X Short IREN Daily ETF上涨27.05%。Tradr 2X Short AAOI Daily ETF上涨26.61%。该产品两倍做空光子学芯片公司Applied Optoelectronics，底层公司股价走弱，杠杆机制放大当日涨幅。Tradr 2X ShortCBRS Daily ETF上涨22.27%。美股ETF跌幅Top5DEFIANCE DAILY TARGET 2X LONG LMND ETF下跌48.02%。2倍做多VRT ETF-GraniteShares下跌33.92%。纳指三倍做空ETF上涨6.30%。大宗商品ETF涨幅Top 5二倍做多彭博原油ETF上涨10.79%。二倍做空黄金矿业指数ETF-Direxion上涨2.09%。行业指数ETF涨幅Top 5三倍做空半导体ETF-Direxion Daily上涨16.35%。债券ETF涨幅Top 5FlexShares iBoxx 3 Year Target Duration TIPS Index Fund上涨0.25%。Vanguard Short-Term In","market":"us","thumbnail":"https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XW","WIA","MNRS","SPYM","USL","USOI","AAOZ","QMmain","QQQX","IXC","IBID","IE00B19Z4B17.USD","NBIL","SPYH","UCO","SMDD","IREN","TIPD","NVOH","ONTX","SAA","LIAT","GPIQ","BNO","DWT","IBIJ","IRE","IREZ","STIP","IWM","STOT","TWM","TQQQ","NUGT","TIP.AU","BK4535","LIAU","OIH","HIBL","IBII","BK4023","DAPP","SPYU","BK4588","IBIK","UPRO","COWZ","QLD","SCO","BK4141","DRIP","FGDL","CLmain","GUSH","HIMZ","LIAM","NJUL","YMmain","DBO","HIYY","STPZ","AAOI","QQQM","BK4609","LIAQ","LMNX","QID","FDIG","NVTC","NRGZ","URTY","XES","BK4600","COZX","BAR","FLBR","ERX.AU","IREG","NBIG","BK4549","NBIZ","SH","SOXS","WTIU","LMND","HIBS","BK4020","TDTT","BK4007","CBRS","SPIP","TIP","OILK","IE0031619046.USD","LIAK","BNDW","FBZ","SKF.AU","IVV","PBTP","VDE","IBLC","FCLD","LIAJ","OILU","BK4116","AAAU","GTIP","IAU","LU0329931090.USD","RIZE","SPXU","SQQQ","DXD","NBIS","PXJ","CBRZ","QQQ","HMYY","SPY","SRTY","TQQY","SPXL","DIA","ERX","LU0531971165.HKD","FTXN","LIAP","LU0950373646.USD","SSO","DUST","BK4608","LU0823431563.USD","USE","BGLD","GLL","QDEC","SIMX","SPXS","DOG","BITQ","BK7016","512480","DULL","SDOW","UDOW","RBIL","IEO","LU0823431647.USD","NVOX","BK4595","KGLD","WGMI","LIAO","SHNY","BK4107","TIPZ","DDG","PXE","UGL","SDS","USG","SCHP","STCE","BK4548","LIBD","IE00B7SZL793.SGD","MMAX","BK4097","ETNG","NAPR","XITK","VRC","DDM","DGP","SPXT","BK7062","BK4550","TIPB","OSSL","UGA","IBIE","MCLmain","IBIB","IBIL","IGLD","BK4593","LAZR","NJAN","VRTL","BKCH","FDN","YSPY","APLX","PSQ","FNGD","GLD","IBIM","IBIH","DIG","DFIP","LIAX","APLZ","BK7095","BK4570","USO","TZA","DRLL","RGTC","DZZ","VTP","SGDJ","MVV","KEEX","SMAX","SPYQ","XOP","DGZ","NOCT","BK4585","IBIF","LITC","LU0329931173.USD","NEBX","VRC.AU","YGLD","HIMY","BK4077","IE00B66KJ199.SGD","NBIC","SPDN","DBE","LIAW","OILT","TIPA","DBC","SPUU","AAOX","BK4516","WTID","GLDM","FAAR","BZmain","TEUP","QMAR","RWM","UWM","IAUM","VOO","IBIG","IREX","TNA","IAUI","DMAX","FAZ","APLD","DUG","GLDY","ALA","OILD","SGOL","SKF","VTIP","BK4551","VTWO","IBIC","OUNZ"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2655918238","title":"諾和諾德因新一代減重新藥遭股東起訴始末","url":"https://stock-news.laohu8.com/highlight/detail?id=2655918238","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655918238?lang=zh_tw&edition=fundamental","pubTime":"2026-07-29 22:42","pubTimestamp":1785336120,"startTime":"0","endTime":"0","summary":"诺和诺德一名发言人回应称，公司坚信相关指控毫无依据，会积极全力应诉抗辩。诺和诺德否认自身存在任何违规过错。一众诺和诺德股东起诉这家药企，矛头直指在研减重药CagriSema。本次股东诉讼与诺和诺德起诉礼来相互独立本次股东诉讼，和诺和诺德近期起诉礼来的商业纠纷没有关联。在实体庭审正式开庭前，诺和诺德仍可持续举证抗辩。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-07-29/doc-iniknvww9945361.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4007","LU0154236417.USD","NVOH","OZEM","NVOX","BK4585","IE00BZ1G4Q59.USD","BK4532","LU1093756168.USD","THNR","IE00BKVL7J92.USD","NVO","PPH","BK4588","LU1093756325.SGD","BK4599"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}